“Integrated Approaches for Identifying Molecular Targets in Liver Disease”
To provide a framework for successful clinical trials testing novel targets for therapy in liver disease. To identify molecular and cellular drivers of liver disease to provide a molecular classification and study the determinants or key drivers of disease progression. Consecutive patients admitted with steatohepatitis (alcoholic or non-alcoholic) will be enrolled in this study where liver tissue, blood and stool will be collected to discover and validate factors associated with diagnosis, severity, histological characteristics, development of decompensations, progression of disease and survival.
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
Integrated Approaches for Identifying Molecular Targets in Liver Disease